Shenyang Xingqi Pharmaceutical Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 599.19 million compared to CNY 461.26 million a year ago. Revenue was CNY 600.57 million compared to CNY 462.36 million a year ago.

Net income was CNY 120.63 million compared to CNY 80.14 million a year ago. Basic earnings per share from continuing operations was CNY 1.37 compared to CNY 0.99 a year ago. Diluted earnings per share from continuing operations was CNY 1.37 compared to CNY 0.99 a year ago.